Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2018160 Title: FORMULATIONS A LIBERATION MODIFIEE CONTENANT DES COMPLEXES MEDICAMENT - RESINE ECHANGEUSE D'IONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
077532174
WO application number:
US2007006572
Type:
European patent granted for BE
Status:
Open
Publication number:
2018160
WO publication number:
WO 2007/109104
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
15/03/2007
Grant date:
14/12/2011
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
28/02/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
14/12/2011
EP B1 publication date:
14/12/2011
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
15/03/2027

Applicant

Name:
Tris Pharma, Inc.
Legal Form:
From:
14/12/2011
Address:
2033 Route 130 Suite D., Monmouth Junction NJ 08852, United States (US)
To:

Agent

Name:
LAENEN Bart
Legal Form:
From:
28/02/2012
Address:
Kempische Steenweg 542A, 3500, HASSELT, Limburg, Belgium (BE)
To:

Inventor

1

Name:
MEHTA, Ketan
Legal Form:
Address:

2

Name:
TU, Yu-hsing
Legal Form:
Address:

Priority

Priority patent number:
783181
Priority date:
16/03/2006
Priority country:
United States (US)

Classification

Main IPC class:
A61K 9/58;
IPC or IDT classification:
A61K 9/10; A61K 9/16; A61K 9/20; A61K 47/48;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2011/12
Publication date:
31/12/2011
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

Annual fee

Annual fee(s) Due Date:
31/03/2026
Annual fee number:
20
Annual fee amount:
600 Euro
Expected payer:
Last annual fee payment date:
27/02/2025
Last annual fee paid number:
19
Last annual fee paid amount:
555 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
04/07/2023 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /0/6/1/8/1/0612018160/docs/077532174_0_rfc_20230706_103357127.pdf
28/02/2012 General Document (F - F:Traduction déposée par fax) 96 PDF /0/6/1/8/1/0612018160/migrated-docs/077532174_1_288771.pdf
06/03/2012 General Document (OF - T:Traduction Originale de la traduction déposée par fax) 96 PDF /0/6/1/8/1/0612018160/migrated-docs/077532174_2_288771.pdf